Free Trial

NewAmsterdam Pharma (NAMS) Institutional Ownership

→ 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad)
Free NAMS Stock Alerts
$20.09
+0.04 (+0.20%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMS)

Current
Institutional Ownership
Percentage
89.89%
Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$304.42M
Number of
Institutional Sellers
(last 12 months)
0
Get NAMS Insider Trade Alerts

Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NAMS Institutional Buying and Selling by Quarter

NewAmsterdam Pharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024 Artal Group S.A.800,000$18.92M0.5%N/A0.896%
5/16/2024 Janus Henderson Group PLC636,231$15.02M0.0%N/A0.713%
5/15/2024 Baker BROS. Advisors LP96,827$2.29M0.0%N/A0.108%
5/15/2024 Affinity Asset Advisors LLC286,200$6.77M0.8%+129.0%0.321%
5/14/2024 StemPoint Capital LP80,334$1.90M0.5%N/A0.090%
5/7/2024 TimesSquare Capital Management LLC228,616$5.41M0.1%N/A0.256%
5/2/2024 Jennison Associates LLC930,851$22.02M0.0%N/A1.043%
4/10/2024 Yarbrough Capital LLC23,960$567K0.0%N/A0.027%
3/7/2024 Fcpm Iii Services B.V.11,831,461$132.16M39.2%N/A14.373%
2/15/2024 Opaleye Management Inc.265,388$2.96M0.8%N/A0.325%
2/15/2024 Parkman Healthcare Partners LLC300,750$3.36M0.5%+20.8%0.369%
2/1/2024 Wolverine Asset Management LLC8,694$97K0.0%+197.2%0.011%
11/15/2023 Affinity Asset Advisors LLC125,000$1.16M0.3%+25.0%0.153%
11/14/2023 Schonfeld Strategic Advisors LLC64,700$598K0.0%+12.9%0.079%
11/13/2023 Wolverine Asset Management LLC2,925$27K0.0%N/A0.004%
8/21/2023 Affinity Asset Advisors LLC100,000$1.19M0.4%N/A0.123%
8/15/2023 RA Capital Management L.P.9,000,000$107.01M2.0%+125.0%11.035%
8/15/2023 Bain Capital Life Sciences Investors LLC10,473,913$124.54M12.8%+26.2%12.842%
8/10/2023 Monashee Investment Management LLC95,000$1.13M0.3%N/A0.116%
8/4/2023 Maven Securities LTD25,000$297K0.0%N/A0.031%
7/19/2023 Medicxi Ventures Management Jersey Ltd2,869,565$34.12M9.6%+43.5%3.518%
7/14/2023 Venture Visionary Partners LLC10,000$119K0.0%N/A0.012%
5/9/2023 GMT Capital Corp1,083,800$14.37M0.6%+8.4%6.106%
5/8/2023 Wolverine Asset Management LLC4,819$64K0.0%N/A0.027%
2/14/2023 RA Capital Management L.P.4,000,000$43.60M0.9%N/A22.535%
2/3/2023 Frazier Life Sciences Management L.P.9,341,551$101.82M6.3%N/A52.628%
2/3/2023 GMT Capital Corp1,000,000$10.90M0.5%N/A5.634%
1/31/2023 Medicxi Ventures Management Jersey Ltd2,000,000$21.80M9.2%N/A11.268%
(Data available from 1/1/2016 forward)

NAMS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NAMS shares?

During the previous two years, 21 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Fcpm Iii Services B.V. ($132.16M), Bain Capital Life Sciences Investors LLC ($124.54M), RA Capital Management L.P. ($107.01M), Frazier Life Sciences Management L.P. ($101.82M), Medicxi Ventures Management Jersey Ltd ($34.12M), Jennison Associates LLC ($22.02M), and Artal Group S.A. ($18.92M).Learn more on NAMS's institutional investors.

What percentage of NewAmsterdam Pharma stock is owned by institutional investors?

89.89% of NewAmsterdam Pharma stock is owned by institutional investors. Learn more on NAMS's institutional investor holdings.

Which institutional investors have been buying NewAmsterdam Pharma stock?

Of the 21 institutional investors that purchased NewAmsterdam Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fcpm Iii Services B.V. ($11.83M), Frazier Life Sciences Management L.P. ($9.34M), RA Capital Management L.P. ($9M), Medicxi Ventures Management Jersey Ltd ($2.87M), Bain Capital Life Sciences Investors LLC ($2.17M), GMT Capital Corp ($1.08M), and Jennison Associates LLC ($930.85K).

How much institutional buying is happening at NewAmsterdam Pharma?

Institutional investors have bought a total of 39,851,336 shares in the last 24 months. This purchase volume represents approximately $483.72M in transactions.


Related Companies:
This page (NASDAQ:NAMS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Elon’s New Device is About to Shock the World
InvestorPlace
Biden Nomination CANCELED?
The Freeport Society
Urgent Nvidia Warning
Altimetry
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Most important medical advance in 100 years
The Oxford Club